Cargando…
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
Recent studies on mutations in cancer genomes have distinguished driver mutations from passenger mutations, which occur as byproducts of cancer development. The cancer genome atlas (TCGA) project identified 299 genes and 24 pathways/biological processes that drive tumor progression (Cell 173: 371-38...
Autores principales: | Chang, Soojeong, Yim, Sujin, Park, Hyunsung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586683/ https://www.ncbi.nlm.nih.gov/pubmed/31221981 http://dx.doi.org/10.1038/s12276-019-0230-6 |
Ejemplares similares
-
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing
por: Rondinelli, Beatrice, et al.
Publicado: (2015) -
Contingencies of UTX/KDM6A Action in Urothelial Carcinoma
por: Lang, Alexander, et al.
Publicado: (2019) -
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
por: Romero, Octavio A., et al.
Publicado: (2021) -
Regulation of KDM5C stability and enhancer reprogramming in breast cancer
por: Xiao, Qiong, et al.
Publicado: (2022) -
Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
por: Shigekawa, Yoshinobu, et al.
Publicado: (2018)